Skip to main content
Signal8
Gupta Shalabh K. profile photo

Shalabh K. Gupta

CIK: 0001864917

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Unicycive Therapeutics, Inc. logo
UNCY

Unicycive Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Unicycive Therapeutics, Inc. logo
    UNCY

    Unicycive Therapeutics, Inc.

    May 14, 2026
    Award(A)

    Restricted Stock Units

    Direct
    762.2K shares-
  • Unicycive Therapeutics, Inc. logo
    UNCY

    Unicycive Therapeutics, Inc.

    May 14, 2026
    Award(A)

    Restricted Stock Units

    Direct
    762.2K shares-
  • Unicycive Therapeutics, Inc. logo
    UNCY

    Unicycive Therapeutics, Inc.

    Jul 28, 2025
    Award(A)

    Stock Options

    Direct
    325K shares-

1-3 of 3

About Gupta Shalabh K.

Gupta Shalabh K. (SEC CIK 0001864917) files insider reports with the SEC as CEO of Unicycive Therapeutics, Inc. (UNCY).

Signal8 holds 3 ownership filings by Gupta Shalabh K., all Form 4s, filed between Jul 30, 2025 and Jun 15, 2026. Those filings report 3 transactions, from Jul 28, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gupta Shalabh K.'s filings is in MOUNTAIN VIEW, CA.

Recent filings by Gupta Shalabh K.

  • May 14, 2026: Grants or awards of UNCY derivative securities (2 lines, Form 4, code A).
  • Jul 28, 2025: Grant or award of UNCY derivative securities (Form 4, code A).

Other insiders filing for Unicycive Therapeutics, Inc. (UNCY)

How to read Form 4 transaction codes